Holen Sie sich die Stockscreener-App
21.50
0.75%
0.16
Handel nachbörslich:
21.50
Schlusskurs vom Vortag:
$21.34
Offen:
$21.34
24-Stunden-Volumen:
1.13M
Relative Volume:
0.78
Marktkapitalisierung:
$1.84B
Einnahmen:
$1.13B
Nettoeinkommen (Verlust:
$62.75M
KGV:
34.13
EPS:
0.63
Netto-Cashflow:
$170.92M
1W Leistung:
+4.78%
1M Leistung:
-6.36%
6M Leistung:
+38.09%
1J Leistung:
-19.23%
1-Tages-Spanne:
$20.95
$22.02
1-Wochen-Bereich:
$20.25
$22.02
52-Wochen-Spanne:
$13.39
$30.42
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Vergleichen Sie PGNY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
21.50 | 1.76B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
301.91 | 268.12B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
383.84 | 84.11B | 183.12B | 5.92B | 3.67B | 25.63 |
|
CI
Cigna Group
|
316.64 | 84.41B | 254.47B | 5.03B | 6.01B | 18.06 |
|
CVS
Cvs Health Corp
|
64.04 | 76.95B | 378.96B | 5.28B | 5.94B | 4.19 |
|
HUM
Humana Inc
|
233.13 | 27.15B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Progyny (PGNY) Welcomes Elizabeth Bierbower to Its Board of Dire - GuruFocus
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbo - GuruFocus
Progyny appoints Elizabeth Bierbower to board - Investing.com
Progyny appoints Elizabeth Bierbower to board By Investing.com - Investing.com UK
Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors - GlobeNewswire
Former Humana Executive Strengthens Progyny Leadership: Elizabeth Bierbower Brings 30-Year Healthcare Expertise - Stock Titan
When (PGNY) Moves Investors should Listen - news.stocktradersdaily.com
Progyny’s SWOT analysis: fertility benefits firm faces growth challenges By Investing.com - Investing.com Nigeria
Progyny shareholders vote on executive pay and directors - Investing.com India
Progyny Stockholders Meeting Highlights Governance Decisions - TipRanks
Progyny: Robust Expectations In 2025 Amid Growing Expenses (Hold) - Seeking Alpha
Progyny’s SWOT analysis: fertility benefits firm faces growth challenges - Investing.com Australia
Transcript : Progyny, Inc.Shareholder/Analyst Call - marketscreener.com
Progyny, Inc. (NASDAQ:PGNY) Shares Acquired by Bank of America Corp DE - Defense World
Jane Street Group LLC Sells 58,870 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny Inc (PGNY) Stock Price Down 4.39% on May 19 - GuruFocus
Q1 Earnings Outperformers: Progyny (NASDAQ:PGNY) And The Rest Of The Health Insurance Providers Stocks - Yahoo Finance
3 Reasons PGNY is Risky and 1 Stock to Buy Instead - Yahoo Finance
Where are the Opportunities in (PGNY) - news.stocktradersdaily.com
There May Be Reason For Hope In Progyny's (NASDAQ:PGNY) Disappointing Earnings - Yahoo Finance
Progyny, Inc.'s (NASDAQ:PGNY) CEO Will Probably Struggle To See A Pay Rise This Year - simplywall.st
Progyny Appoints Two Renowned Women’s Health Experts to Medical Advisory Board - GlobeNewswire
Progyny adds two renowned doctors to advisory board By Investing.com - Investing.com Nigeria
Progyny at BofA Securities 2025: Expanding Horizons in Fertility Care By Investing.com - Investing.com Nigeria
Progyny at BofA Securities 2025: Expanding Horizons in Fertility Care - Investing.com Australia
Progyny Appoints Two Renowned Women's Health Experts to Medical Advisory Board | PGNY Stock News - GuruFocus
Progyny Appoints Dr. Gloria Richard-Davis and Dr. Whitney Booker to Medical Advisory Board - citybiz
Pogyny (PGNY) Expands Medical Advisory Board with New Appointmen - GuruFocus
Progyny appoints Gloria Richard-Davis, Whitney Booker to Medical Advisory Board - TipRanks
Progyny adds two renowned doctors to advisory board - Investing.com
Progyny Appoints Two Renowned Women's Health Experts to Medical Advisory Board - Quantisnow
What Is Progyny, Inc.'s (NASDAQ:PGNY) Share Price Doing? - Yahoo Finance
Progyny, Inc. to Present at BofA Securities 2025 Health Care Con - GuruFocus
Fund Update: THRIVENT FINANCIAL FOR LUTHERANS added 3,342,834 shares of PROGYNY ($PGNY) to their portfolio - Nasdaq
The Price Is Right For Progyny, Inc. (NASDAQ:PGNY) - simplywall.st
Progyny (NASDAQ:PGNY) Price Target Cut to $21.00 by Analysts at Canaccord Genuity Group - Defense World
Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference - The Manila Times
Canaccord Genuity Lowers Price Target for Progyny (PGNY) to $21. - GuruFocus
Progyny raises 2025 revenue guidance to $1.185B-$1.235B amid robust client expansion - MSN
Progyny price target lowered to $21 from $23 at Canaccord - TipRanks
Amazon (AMZN) Boosts Progyny's Earnings with Enhanced Services | - GuruFocus
First Trust Advisors LP Purchases 2,794 Shares of Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny (NASDAQ:PGNY) Stock Price Down 8.4% on Disappointing Earnings - Defense World
Progyny, Inc. (NASDAQ:PGNY) Q1 2025 Earnings Call Transcript - Insider Monkey
Decoding Progyny Inc (PGNY): A Strategic SWOT Insight - GuruFocus
Progyny, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
PGNY Q1 Earnings Call: Product Expansion, Member Growth, and Guidance Raised - Yahoo Finance
Earnings call transcript: Progyny Q1 2025 beats EPS estimates By Investing.com - Investing.com India
Progyny, Inc. Reports Strong Q1 2025 Results - TipRanks
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.00%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):